Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pharma's New Follow-On Strategy

Feb 01 2008

Related Content

Almirall: Adapting Primary-Care-focused R&D to a Specialist World

Feb 01 2008

Genzyme/Isis: Has ENHANCE Dulled Mipomersen's Prospects?

Feb 01 2008

Bristol Revs Its R&D Engine: An Interview with Elliott Sigal and Francis Cuss

Nov 01 2007

Pharma's R&D Heartburn Spells Opportunity for GI-Focused Biotechs

Nov 01 2007

Restructuring Roche's R&D: An Interview with Lee Babiss

Oct 01 2007

Finding a Way Out of Pharma's Dealmaking Dilemma

Sep 01 2007

Insulin Delivery: Still Waiting to Exhale

Dec 01 2007

The Value Proposition: Why Pharma Should Embrace Comparative Effectiveness

Feb 01 2008

China: The Asian Dragon Lures Foreign Investors

Feb 01 2008

Related Companies

Biogen, Inc.

Sanofi Genzyme

Ionis Pharmaceuticals, Inc.

Pfizer Inc.

Abbott

WuXi AppTec

Sirtris Pharmaceuticals

Genentech, Inc.

Elan Corporation

Roche Holding AG

Amgen, Inc.

Merck & Co., Inc.

GSK plc

Eli Lilly and Company

Daiichi Sankyo Co., Ltd.

Takeda Pharmaceutical Co. Ltd.

Piramal Enterprises Limited

AstraZeneca PLC

Wyeth

Forest Laboratories, Inc.

Sumitomo Pharma Co., Ltd.

Takeda Pharmaceutical Co. Ltd.

Pfizer Inc.

Haptogen Ltd.

Bristol Myers Squibb Company

Ambrx Biopharma, Inc.

BaroFold, Inc.

OctoPlus N.V.

Biolex Therapeutics, Inc.

Endo, Inc.

Allergan plc

General Electric

Takeda Pharmaceutical Co. Ltd.

Reliant Pharmaceuticals

Teva Pharmaceutical Industries Ltd.

Human Genome Sciences, Inc.

Principia Biopharma, Inc.

Additional Topics

Strategy Leadership BioPharmaceutical

More from Leadership

More from In Vivo

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window